Cases & Deals

Baxter Ventures invests in Covagen

Clients Baxter International Inc.

Jones Day represented Baxter Ventures in connection with its purchase of Series B Convertible Preferred Stock in a private placement by Covagen AG, a Swiss biopharmaceuticals company.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.